Characterization of SET/I2PP2A isoforms in dogs. to decreased cell proliferation, invasion and colony formation. Phosphorylation level of p70 S6 kinase was decreased by SET knockdown in CMeC-2, suggesting the involvement of mTOR (mammalian target of rapamycin)/p70 S6 kinase signaling. The SET inhibitors, OP449 and FTY720, more effectively killed CMeC-2 than CMeC-1. We observed PP2A activation in CMeC-2 treated with OP449 and (S)-3-Hydroxyisobutyric acid FTY720. These results demonstrated the potential therapeutic application of SET inhibitors for canine melanoma. media were added on the membrane (upper chamber). 880 of medium with 10% FBS was added on the lower chamber and cultured for 24 hr. The membranes were fixed with methanol for 15 min (S)-3-Hydroxyisobutyric acid and stained with Giemsa solution (Muto Pure Chemicals, Tokyo, Japan). After the membranes were washed with distilled water, non-invaded cells were wiped with cotton-swab. The number of invaded cells through the membranes was randomly counted in 3 fields ( 400) under a light microscope (Eclipse TE2000, Nikon, Tokyo, Japan). of trypsin-EDTA and trypan blue solution was added in an equal volume. Surviving cells were counted by microscopy. test was used for comparison between two groups. Groups more than 3 were compared using one-way analysis of variance, after which Fisher LSD test was used. For all analyses, a probability value of 22: 55C60. doi: 10.1053/j.ctsap.2007.03.004 [PubMed] [CrossRef] [Google Scholar] 2. Blackwood L., Dobson J. M.1996. Radiotherapy of oral malignant melanomas in dogs. 209: 98C102. [PubMed] [Google Scholar] 3. Bulmer J. N.1989. Decidual cellular responses. 1: 1141C1147. doi: 10.1016/0952-7915(89)90006-X [PubMed] [CrossRef] [Google Scholar] 4. Christensen D. J., Chen Y., Oddo J., Matta K. M., Neil J., Davis E. D., Volkheimer A. D., Lanasa M. C., Friedman D. R., Goodman B. K., Gockerman J. P., Diehl L. F., de Castro C. M., Moore J. O., Vitek M. P., Weinberg J. B.2011. SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target. 118: 4150C4158. doi: 10.1182/blood-2011-04-351072 [PMC free article] [PubMed] Myod1 [CrossRef] [Google Scholar] 5. Cotchin E.1955. Melanotic tumours of dogs. 65: 115C129. doi: 10.1016/S0368-1742(55)80011-2 [PubMed] [CrossRef] [Google Scholar] 6. Cristbal I., Garcia-Orti L., Cirauqui C., Cortes-Lavaud X., Garca-Snchez M. A., Calasanz M. J., Odero M. D.2012. Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia. 97: 543C550. doi: 10.3324/haematol.2011.050542 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 7. Dank G., Rassnick K. M., Sokolovsky Y., Garrett L. D., Post G. S., Kitchell B. E., Sellon R. K., Kleiter M., Northrup N., Segev G.2014. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision. 12: 78C84. doi: 10.1111/j.1476-5829.2012.00338.x [PubMed] [CrossRef] [Google Scholar] 8. Dong L., Zhu J., Wen X., Jiang T., Chen Y.2014. Involvement of SET in the Wnt signaling pathway and the development of human colorectal cancer. 7: 1203C1208. [PMC free article] [PubMed] [Google Scholar] 9. Farrell A. S., Allen-Petersen B., Daniel C. J., Wang X., Wang Z., Rodriguez S., Impey S., Oddo J., Vitek M. P., Lopez C., Christensen D. J., Sheppard B., Sears R. C.2014. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer. 12: 924C939. doi: 10.1158/1541-7786.MCR-13-0542 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 10. Fujiwara N., Kawasaki H., Yabe R., Christensen D. J., Vitek M. P., Mizuno T., Sato K., Ohama T.2013. A potential therapeutic application of SET/I2PP2A inhibitor OP449 for canine T-cell lymphoma. 75: 349C354. doi: 10.1292/jvms.12-0366 [PubMed] [CrossRef] [Google Scholar] 11. Goldschmidt M. H., Shofer F. S.1992. Skin Tumors of the Dog and Cat, 1st ed. Pergamon Press, Oxford. [Google Scholar] 12. Hahn K., Miranda M., Francis V. A., Vendrell J., Zorzano A., Teleman A. A.2010. PP2A regulatory subunit PP2A-B counteracts S6K phosphorylation. 11: 438C444. (S)-3-Hydroxyisobutyric acid doi: 10.1016/j.cmet.2010.03.015 [PubMed] [CrossRef] [Google Scholar] 13. Inoue K., Ohashi E., Kadosawa T., Hong S. H., Matsunaga S., Mochizuki M., Nishimura R., Sasaki N.2004. Establishment and characterization of four canine melanoma cell lines. 66: 1437C1440. doi: 10.1292/jvms.66.1437 [PubMed] [CrossRef] [Google Scholar] 14. Janghorban M., Farrell A. S., Allen-Petersen B..